On genomics, NGS, and doing much more good than bad, with Ma...
Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
Newsletters and Deep Dive digital magazine
Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.
Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.
Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Editor's Picks
Newsletters and Deep Dive
digital magazine